Influência do tramadol associado à levobupicavaína epidural sobre a taxa de propofol e variáveis fisiológicas, em cadelas submetidas à mastectomia e à ovário-histerectomia / [Influence of tramadol combined with epidural levobupicavaine, on the propofol infusion rate and physiological variables, in female dogs undergoing mastectomy and ovariohysterectomy]

Objetivou-se avaliar os efeitos fisiológicos e sobre o consumo do propofol, relativos à anestesia epidural com levobupivacaína isolada ou associada a diferentes doses de tramadol. Para tal, 18 cadelas foram pré-tratadas com acepromazina, utilizando-se propofol para indução e manutenção anestésicas. Conforme o protocolo epidural instituído, formaram-se três grupos (n=6) tratados com levobupivacaína isolada (1,5mg/kg) (GL) ou acrescida de 2mg/kg (GLT2) ou 4mg/kg (GLT4) de tramadol, respectivamente. As fêmeas foram submetidas à mastectomia e à ovário-histerectomia (OH), registrando-se as variáveis fisiológicas nos períodos pré (TB e T0) e transanestésicos (T10 a T70), bem como a taxa mínima de propofol necessária. Houve redução da FC para o GL e o GLT4 em relação ao GLT2 (T30 a T70), detectando-se, no GL, redução da PAS e da PAD em relação ao TB. Maiores taxas de infusão do propofol foram necessárias para o GL (0,70±0,12mg/kg/min) em relação ao GLT2 (0,50±0,19mg/kg/min) e ao GLT4 (0,50±0,19mg/kg/min). Conclui-se que o tramadol potencializou o propofol, ao ofertar analgesia, independentemente da dose administrada. Todos os protocolos testados foram seguros e eficazes em cadelas submetidas à mastectomia e à OH.(AU)

The aim of this study was to evaluate the physiological and on propofol-sparing effects related to epidural anesthesia with levobupivacaine alone or combined with different doses of tramadol. For this purpose, 18 female dogs were pretreated with acepromazine, using propofol for induction and maintenance of anesthesia. Based on a previously established epidural (L7-S1) protocol, three groups (n=6) were treated with either levobupivacaine alone (1.5mg.k-1) (GL) or in association with to 2mg.kg-1 (GLT2) or 4mg.kg-1 (GLT4) of tramadol, respectively. These dogs were all undergoing mastectomy and ovariohysterectomy (OH). The physiological data were registered in the pre (TB and T0) and trans-anesthetic periods (T10 - T70), as well as the consumption of propofol. There was a reduction in the HR for GL and GLT4 in relation to GLT2 (T30 - T70) and reductions in SAP and DAP in relation to TB in the GL group. Higher continuous infusion rate of propofol were required for GL (0.70±0.12mg.kg-1.min-1) relative to GLT2 (0.50±0.19mg.kg-1.min-1) and GLT4 (0.50±0.19mg.kg-1.min-1). It was concluded that tramadol potentiated propofol, offering analgesia independently of its administered dose. All protocols tested were safe and effective in female dogs undergoing mastectomy and OH.(AU)

Efeito genotóxico e antiproliferativo de Mikania cordifolia (L. F. ) Willd. (Asteraceae) sobre o ciclo celular de Allium cepa L / Antiproliferative and genotoxic effects of Mikania cordifolia (LF) Willd. (Asteraceae) on the cell cycle of Allium cepa L

As plantas com potencial medicinal têm sido muito utilizadas para o tratamento de doenças no Brasil. O objetivo deste estudo foi avaliar o efeito genotóxico e antiproliferativo de infusões de Mikania cordifolia (L.F.) Willd. sobre o ciclo celular de Allium cepa L. Foram coletadas duas populações no município de Santa Maria, Rio Grande do Sul, e, para cada uma, foram preparados dois tratamentos em duas concentrações: 4g/500mL e 16g/500mL, além de um controle positivo composto por 10% de glifosato em 90% água, um herbicida amplamente utilizado com conhecido potencial genotóxico, e de um controle negativo composto por água destilada. Após período de 24 horas, as radículas foram coletadas das infusões, fixadas em etanol-ácido acético (3:1) por 24 horas e estocadas em etanol 70%. Foram analisadas células em todas as fases do ciclo celular de A. cepa, totalizando 2500, para cada grupo de bulbos. Os índices mitóticos (IM) foram calculados e submetidos à análise estatística pelo teste χ² a 5%. Os resultados mostraram que, em ambas as populações de M. cordifolia, houve redução do IM de todos os tratamentos em relação ao controle negativo. Em ambas as populações, obteve-se aumento nos valores dos índices mitóticos em função do aumento da concentração da infusão. Ocorreram aberrações cromossômicas em ambas as populações estudadas. Concluiu-se que as infusões de M. cordifolia, nas concentrações estudadas, possuem efeito antiproliferativo e mutagênico sobre o ciclo celular de A. cepa.

Potential medicinal plants have been widely used for the treatment of diseases in Brazil. The objective of this study was to evaluate the genotoxic and antiproliferative effects of infusions of Mikania cordifolia (LF) Willd. on the cell cycle of Allium cepa L. Two populations were collected in Santa Maria, Rio Grande do Sul, Brazil. For each one, two treatments were prepared in different concentrations: 4g/500mL and 16g/500mL. A positive control consisting of 10% glyphosate in 90% water, which is an herbicide widely used and known for its genotoxic potential, was also prepared. Distilled water was used as negative control. After a 24-hour period, the infusion of the root tips was collected, fixed in ethanol-acetic acid (3:1) for 24 hours and stored in 70% ethanol. Cells were analyzed in all phases of the cell cycle of A. cepa, a total of 2500, for each group of bulbs. The mitotic index (MI) was calculated and statistically analyzed by the χ² test at 5%. Results showed that, in both populations of M. cordifolia, a reduction of the MI in all treatments compared with the negative control was observed. In both populations, an increase in the mitotic index values was obtained with increasing concentration of the infusion. Chromosomal aberrations were observed in both populations studied. In conclusion, infusions of M. cordifolia possess antiproliferative and mutagenic effects for the concentrations tested on the cell cycle of A. cepa.

Fractured zona oocytes in in-vitro fertilization cycles stimulated with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin.

In order to assess the possible influence of gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin on the occurrence of fractured zona oocytes (FZOs) in in-vitro fertilization (IVF) treatment cycles, we analysed 267 consecutive cycles in 199 patients. In 87 cycles, at least one fractured zona oocyte was recovered, and in 180 cycles only intact zona oocytes (IZOs) were recovered. FZOs represented 5.8% of all oocytes retrieved and 14.8% when only cycles with FZOs were considered. Serum oestradiol concentrations were significantly higher at day -3 and day -2 (P < 0.02) in cycles yielding at least one fractured zona oocyte compared to IZO cycles (day 0 = retrieval day), and there was a higher incidence of G terminal pattern of oestradiol curve (P < 0.01) in cycles with FZOs. The mean numbers of all oocytes retrieved and of mature oocytes were significantly higher in FZO than in IZO cycles (P < 0.001). The fertilization rate of mature oocytes was significantly reduced (P < 0.05) in cycles with one or more oocytes with fractured zonae. There was no significant difference in the number of embryos transferred, pregnancy and abortion rates in both groups. We conclude that although the occurrence of fractured zona oocytes is a frequent event, it does not affect the overall results of our IVF programme. Zona pellucida fragility may be the result of over-maturation of some oocytes.